Skip to main content

Want a detailed portfolio tracker?

Ocular Therapeutix (OCUL) P/E (2014 - 2026)

Ocular Therapeutix (OCUL) P/E from Jul 25, 2014 to Jul 21, 2026. The TTM Ocular Therapeutix (OCUL) P/E is -5.98. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Ocular Therapeutix (OCUL)

YearP/EChange
2026-5.98-26.57%
2025-8.14+18.28%
2024-6.89+32.78%
2023-5.19+42.43%
2022-3.64-95.54%
2021-81.58+807.29%
2020-8.99+323.75%
2019-2.12-19.11%
2018-2.62+31.99%
2017-1.99-59.29%
2016-4.88-13.80%
2015-5.66-53.10%
2014-12.08N/A

Comparison Ocular Therapeutix (OCUL) P/E with competitors

Ocular Therapeutix (OCUL) P/E is -5.98.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.00-100.07%
ENLVEnlivex Ltd0.07-101.25%
FGENFibroGen Inc0.24-104.01%
CHRSCoherus Biosciences Inc0.85-114.19%
FBIOFortress Biotech Inc0.95-115.87%
ORMPOramed Pharmaceuticals Inc1.50-125.13%
AGENAgenus Inc3.01-150.32%
INVAInnoviva Inc3.15-152.73%
VXRTVaxart Inc3.55-159.35%
CRMDCorMedix Inc3.63-160.67%
CVACCureVac N.V.4.45-174.33%
GLPGGalapagos NV4.86-181.24%
SRPTSarepta Therapeutics Inc4.88-181.63%
ABEOAbeona Therapeutics Inc5.39-190.08%
ABUSArbutus Biopharma Corp5.60-193.56%
ZVRAZevra Therapeutics Inc5.89-198.43%
SPROSpero Therapeutics Inc6.23-204.14%
CGENCompugen Ltd6.31-205.57%
RIGLRigel Pharmaceuticals6.87-214.90%
SLXNSilexion Therapeutics Corp7.30-221.99%
OMEROmeros Corporation9.26-254.81%
AUPHAurinia Pharmaceuticals Inc9.58-260.26%
PLXProtalix BioTherapeutics Inc10.89-282.10%
ACADAcadia Pharmaceuticals Inc11.73-296.10%
TBPHTheravance Biopharma Inc12.26-305.02%
ADMAAdma Biologics Inc12.42-307.63%
HRMYHarmony Biosciences Holdings Inc13.82-331.07%
SABSSAB Biotherapeutics Inc14.14-336.36%
NAGENiagen Bioscience Inc14.82-347.76%
INCYIncyte Corp15.82-364.55%
REGNRegeneron Pharmaceuticals Inc15.86-365.12%
PBYIPuma Biotechnology Inc17.32-389.52%
CPRXCatalyst Pharmaceuticals Inc17.44-391.58%
EXELExelixis Inc17.54-393.23%
TGTXTG Therapeutics Inc18.97-417.11%
MDXGMimedx Group Inc20.55-443.64%
XOMAXOMA Royalty Corp22.87-482.47%
ARGXArgen X SE24.30-506.27%
CTMXCytomX Therapeutics Inc24.82-515.02%
XOMAOXOMA Royalty Corp25.34-523.78%
HALOHalozyme Therapeutics Inc25.62-528.44%
XOMAPXOMA Royalty Corp25.67-529.21%
VRTXVertex Pharmaceuticals Inc27.99-568.08%
RPRXRoyalty Pharma plc - Class A28.69-579.67%
SLNOSoleno Therapeutics Inc29.02-585.15%
ASNDAscendis Pharma A/S30.09-603.04%
LGNDLigand Pharmaceuticals Inc - Class B37.91-733.90%
APLSApellis Pharmaceuticals Inc39.02-752.45%
BMRNBiomarin Pharmaceutical Inc42.21-805.80%
KRYSKrystal Biotech Inc45.34-858.16%
ONCBeiGene Ltd69.54-1262.74%
PHARPharming Group N.V.75.03-1354.46%
TECHBio-Techne Corp101.96-1804.78%
VCELVericel Corp109.92-1937.93%
ALNYAlnylam Pharmaceuticals Inc117.96-2072.42%
GMABGenmab140.29-2445.72%
TLXTelix Pharmaceuticals Ltd162.15-2811.26%
CORTCorcept Therapeutics Inc212.86-3659.06%